SCHEMBL30982401

SCHEMBL30982401

CCCCCCCCCCCCCCn1ccc(=O)c(O)c1CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.42
▸ KDM6A O15550 1/20 0.42
▸ KDM4A O75164 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ KDM5C P41229 1/20 0.42
▸ KDM2B Q8NHM5 1/20 0.42
▸ DOHH Q9BU89 1/20 0.42
▸ KDM2A Q9Y2K7 1/20 0.42
▸ APP P05067 1/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.42
▸ HTT P42858 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ TYR P14679 3/20 0.39
▸ PTGS1 P23219 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30982990 1.00 KDM4E (0.42) KDM4EKDM6AKDM4ACYP2C9CYP2C19
SCHEMBL30982374 1.00 KDM4E (0.42) KDM4EKDM6AKDM4ACYP2C9CYP2C19
SCHEMBL30982470 0.92 MGLL (0.47) KDM4EAPPHRH3HTTSMN1; SMN2
SCHEMBL9479895 0.88 KDM4E (0.42) KDM4EKDM6AKDM4ACYP2C9CYP2C19
SCHEMBL5515462 0.87 KDM4E (0.47) KDM4EKDM6AKDM4ACYP2C9CYP2C19
Hydrochloric Acid SCHEMBL9478707 0.86 APP (0.41) KDM4EKDM6AKDM4ACYP2C9CYP2C19
SCHEMBL9476440 0.86 KDM4E (0.43) KDM4EKDM6AKDM4ACYP2C9CYP2C19
SCHEMBL10926016 0.86 APP (0.56) KDM4EKDM6AKDM4ACYP2C9CYP2C19
SCHEMBL5179451 0.86 APP (0.56) KDM4EKDM6AKDM4ACYP2C9CYP2C19
SCHEMBL30982984 0.86 APP (0.56) KDM4EKDM6AKDM4ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 — — US disclosed
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 — — US disclosed
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 INFINEUM INTERNATIONAL LIMITED (US) 2025-12-23 — — US disclosed
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240294842-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-4 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240294841-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-3 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240287405-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE - 1 INFINEUM INTERNATIONAL LIMITED (US) 2024-08-29 — — US disclosed
EP-4417673-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417672-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417674-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417675-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
CN-118516151-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516152-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516154-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516153-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 SIGMAR1, OXGR1, OPRM1 KDM4E 2896/4885KDM6A 2173/4885KDM4A 2712/4885
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 PHOSPHO1, SIGMAR1, SGMS1 KDM4E 2276/4885KDM6A 2294/4885KDM4A 2324/4885
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 SIGMAR1, PHOSPHO1, SGMS1 KDM4E 3439/4885KDM6A 2231/4885KDM4A 3691/4885
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 SIGMAR1, OXGR1, OPRM1 KDM4E 2896/4885KDM6A 2173/4885KDM4A 2712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback